Alaya Legal

Policy on Foreign Direct Investment in the Pharmaceutical Sector (November 29, 2013)

Home / Articles

Policy on Foreign Direct Investment in the Pharmaceutical Sector (November 29, 2013)

Policy on Foreign Direct Investment in the Pharmaceutical Sector (November 29, 2013)

The Cabinet reviewed the policy on FDI in the pharmaceutical sector. As per Press Release dated November 29, 2013, the Cabinet has decided that the current policy in brownfield and greenfield projects in the pharmaceutical sector will continue subject to the additional condition that in all cases of FDI in brownfield pharma, there will not be any non-compete clause in any of the inter se agreements.

Avatar

alayalegal

Most Recent Posts

Reach out

Category

Tags

Disclaimer

The Bar Council of India Rules do not permit law firms to solicit work or advertise. By clicking the ‘I Agree’ button, the Reader accepts that they are seeking information on their own accord. Alaya Legal shall in no way be responsible for any technical inaccuracies on this website, or for any actions taken or not taken based on the information contained herein or accessed through this website. Readers are advised to seek counsel from a qualified professional while dealing with specific issues.

By continuing to use this site, you consent to the use of cookies on your device as mentioned in this Cookie Policy .

The views appearing under various sections, including ‘Trending’, are solely those of the respective author. The author may be contacted by writing to Alaya Legal at contact@alayanew.instantlywebsite.com .

Nothing contained on this website shall be construed as legal advice. Readers are encouraged to obtain independent legal counsel for advice relating to their specific circumstances.